SiBone (NASDAQ:SIBN) and Acme United (NYSE:ACU) Financial Comparison

SiBone (NASDAQ:SIBN – Get Free Report) and Acme United (NYSE:ACU – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Analyst Ratings

This is a breakdown of recent recommendations for SiBone and Acme United, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SiBone 1 0 7 0 2.75
Acme United 0 1 0 0 2.00

SiBone presently has a consensus target price of $25.00, suggesting a potential upside of 6.66%. Acme United has a consensus target price of $70.00, suggesting a potential upside of 2.25%. Given SiBone’s stronger consensus rating and higher probable upside, equities research analysts plainly believe SiBone is more favorable than Acme United.

Institutional and Insider Ownership

98.1% of SiBone shares are owned by institutional investors. Comparatively, 62.1% of Acme United shares are owned by institutional investors. 4.0% of SiBone shares are owned by insiders. Comparatively, 29.5% of Acme United shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

SiBone has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Acme United has a beta of 0.35, suggesting that its share price is 65% less volatile than the S&P 500.

Valuation and Earnings

This table compares SiBone and Acme United”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SiBone $200.93 million 5.26 -$18.90 million ($0.31) -75.61
Acme United $220.55 million 1.23 $17.79 million $2.72 25.17

Acme United has higher revenue and earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Acme United, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares SiBone and Acme United’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SiBone -6.20% -7.57% -5.55%
Acme United 10.25% 9.70% 6.10%

Summary

Acme United beats SiBone on 8 of the 14 factors compared between the two stocks.

About SiBone

(Get Free Report)

SI-BONE, Inc. is a medical technology company focused on surgical solutions for conditions affecting the sacroiliac (SI) joint and related pelvic anatomy. Founded in 2008, the company develops implants and instruments used by surgeons in procedures involving the SI joint. Its products include the iFuse Implant System, a minimally invasive approach to SI joint fusion, along with related implant systems designed for SI joint and pelvic fixation procedures. SI-BONE also offers surgical instruments and training resources for healthcare professionals.

About Acme United

(Get Free Report)

Acme United Corporation is a supplier of cutting, measuring, and safety products for consumers, businesses, and institutions. Its products include scissors, shears, knives, rulers, and other school and office supplies, as well as first aid kits and related medical and safety products. The company sells products under brands including Westcott, Clauss, Camillus, First Aid Only, and PhysiciansCare. Its offerings serve retail, education, office, industrial, and healthcare markets, with sales in the United States and internationally.

Receive News & Ratings for SiBone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SiBone and related companies with MarketBeat.com's FREE daily email newsletter.